Mimedx (MDXG) Net Cash Flow (2011 - 2026)

Mimedx (MDXG) has 16 years of Net Cash Flow data on file, last reported at -$6.3 million in Q1 2026.

• For the quarter ending Q1 2026, Net Cash Flow fell 415.04% year-over-year to -$6.3 million; the trailing twelve-month figure through Mar 2026 stood at $53.3 million (down 9.4% YoY), and the FY2025 full-year result was $61.7 million, up 164.31% from the prior year.
• Net Cash Flow eased to -$6.3 million in Q1 2026, from $24.0 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $24.0 million in Q4 2025 to a low of -$33.5 million in Q1 2024.
• A 5-year average of $4.9 million and a median of $2.7 million in 2022 frame the typical range for Net Cash Flow.
• Across the five-year window, Net Cash Flow surged 1693.15% in 2023 and slumped 41274.07% in 2024, its largest moves.
• Tracing MDXG's Net Cash Flow over 5 years: stood at $2.7 million in 2022, then tumbled by 413.23% to -$8.3 million in 2023, then surged by 287.83% to $15.6 million in 2024, then soared by 53.95% to $24.0 million in 2025, then tumbled by 126.41% to -$6.3 million in 2026.
• Business Quant data shows MDXG's Net Cash Flow at -$6.3 million in Q1 2026, $24.0 million in Q4 2025, and $23.2 million in Q3 2025.